DP-R213 Phase 1 Pharmacokinetics Study

Condition:   Healthy Interventions:   Drug: DP-R213;   Drug: Raloxifene;   Drug: Cholecaliferol Sponsor:   Alvogen Korea Not yet recruiting - verified January 2017

Source: ClinicalTrials.gov - January 3, 2017 Category: Research Source Type: clinical trials